Gus Khursigara
Vice President, Medical Affairs and Clinical Strategy at Inozyme Pharma - Boston, MA, US
Gus Khursigara's Colleagues at Inozyme Pharma
Gus Khursigara's Contact Details
857-330-4340
Greater New York City Area
Inozyme Pharma
Gus Khursigara's Company Details
We are a biopharmaceutical company specializing in the development of novel therapeutics to treat rare metabolic diseases. Our lead product candidate is INZ-701, an enzyme replacement therapy (ERT) in the early stages of clinical development for the potential treatment of patients with a variety of calcification disorders linked primarily to mutations in the ENPP1 and ABCC6 genes, or ENPP1 Deficiency and ABCC6 Deficiency respectively. We have demonstrated proof of concept with INZ-701 in both GACI and ARHR2 two phenotypes of ENPP1 Deficiency.